(-)-Epicatechin Promotes Epigenetic and Metabolic Changes in an Obesity Model

Area of Science:

• Epigenetics
• Nutritional Science
• Molecular Biology

Background:

• Obesity is a complex chronic disease linked to environmental factors and comorbidities.
• DNA methylation is an epigenetic mechanism implicated in obesity development.
• (-)-Epicatechin (EC), a flavanol, shows promise for managing overweight individuals by potentially influencing gene regulation.

Purpose of the Study:

• To investigate whether EC can modulate DNA methylation changes associated with obesity.
• To explore the epigenetic mechanisms underlying EC's effects on obesity.

Main Methods:

• In silico analysis of EC interactions with DNA methyltransferases (DNMTs).
• In vitro assessment of DNMT activity in the presence of EC.
• In vivo study in a diet-induced obesity mouse model to evaluate global DNA methylation, DNMT expression, and key metabolic genes in visceral adipose tissue and skeletal muscle.

Main Results:

• EC demonstrated stable interactions with DNMTs and inhibited their activity in a concentration-dependent manner.
• An obesogenic diet reduced global DNA methylation and DNMT expression in mice; EC partially restored these in skeletal muscle but had limited effects in visceral adipose tissue.
• EC increased mitochondrial DNA content in both skeletal muscle and visceral adipose tissue.

Conclusions:

• EC acts as an epigenetic modulator, potentially inhibiting DNMT activity and reversing obesity-related epigenetic alterations, particularly in skeletal muscle.
• EC promotes mitochondrial biogenesis, indicated by increased mitochondrial DNA content.
• EC shows potential as a therapeutic agent for obesity-related dysfunctional tissues.